Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    Welcome !
    My account
    Logout

Retrophin, Inc. (RTRX) Stock Forecast 2025 - AI Price Prediction & Analysis

Retrophin, Inc. (RTRX) AI Stock Price Forecast & Investment Analysis

Retrophin, Inc. Stock Price Chart and Technical Analysis

Loading Retrophin, Inc. interactive price chart and technical analysis...

Retrophin, Inc. (RTRX) - Comprehensive Stock Analysis & Investment Research

Deep dive into Retrophin, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Retrophin, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Retrophin, Inc.: Retrophin, Inc. operates in the Health Technology sector, making it an emerging small-cap investment.

Retrophin, Inc. (Stock Symbol: RTRX) is a leading company in the Health Technology sector , specifically operating within the Biotechnology industry.

The organization employs approximately 221 professionals worldwide and operates under the strategic leadership of CEO Eric Dube.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Retrophin, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Retrophin, Inc.: With $194M in annual revenue and -40.2% net margin, the company demonstrates developing profitability.

Annual Revenue: $194 million generating a -40.2% net profit margin .

Market Capitalization: $1091 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -28.5% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Retrophin, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Retrophin, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Retrophin, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Retrophin, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Retrophin, Inc.: Market positioning analysis based on available financial and operational metrics.

Retrophin, Inc. strategically competes in the highly dynamic Biotechnology marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 97.0% gross margin, indicating strong pricing power and operational efficiency.

Retrophin, Inc. (RTRX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Retrophin, Inc. stock analysis.

Loading Retrophin, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Retrophin, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Retrophin, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Retrophin, Inc.: With a P/E ratio of -14.02, the market sees the stock as potentially undervalued.

P/E Ratio -14.02x
P/B Ratio 4.11x
Market Cap $1091M
EPS $-1.73
Book Value/Share $5.90
Revenue/Share $4.31
FCF/Share $-1.74
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Retrophin, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Retrophin, Inc.: An ROE of -28.5% indicates room for improvement in shareholder value creation.

ROE -28.5%
ROA -12.0%
ROIC -14.2%
Gross Margin 97.0%
Operating Margin -44.2%
Net Margin -40.2%
EBT Margin -50.0%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Retrophin, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Retrophin, Inc.: A current ratio of 6.60 indicates strong liquidity.

Current Ratio 6.60x
Quick Ratio 6.43x
D/E Ratio 0.71x
Financial Leverage 2.30x
Interest Coverage -4.1x
Working Capital $334M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Retrophin, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Retrophin, Inc.: Free cash flow of $-53M indicates cash challenges that need attention.

Operating Cash Flow $-33M
Free Cash Flow $-53M
Capital Spending $-20M
FCF/Sales -27.5%
CapEx/Sales 10.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Retrophin, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Retrophin, Inc.: An asset turnover of 0.30x suggests room for improvement in asset utilization.

Asset Turnover 0.30x
Receivables Turnover 12.2x
Inventory Turnover 0.9x
Fixed Assets Turnover 45.1x
Days Sales Outstanding 30 days
Days Inventory 395 days
Payables Period 735 days
Cash Conversion Cycle -309 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Retrophin, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Retrophin, Inc.: With annual revenue of $194M, Retrophin, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $194M
Operating Income $-86M
Net Income $-78M
R&D Expense $67M
SG&A Expense $66M
Cost of Goods Sold $3M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 72%
Cash & Short-term Investments 66%
Total Liabilities 56%
Short-term Debt 3%
Accounts Receivable 4%
Inventory 1%
Dividend & Shareholder Information
Shares Outstanding 45M

Latest Retrophin, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Retrophin, Inc. (RTRX) stock price and investment outlook.

, source: San Antonio Express-News

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of ...

, source: Insider Monkey

In this article you are going to find out whether hedge funds think Retrophin Inc (NASDAQ:RTRX) is a good investment right now. We like to check what the smart money thinks first before doing ...

, source: Fox Business

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of ...

, source: The New York Times

This documentary grasps at straws trying to prove that the former pharmaceutical executive Martin Shkreli might not be as loathsome as his reputation suggests. By Ben Kenigsberg Christie Smythe helped ...

, source: Houston Chronicle

What: Shares of Retrophin, a small-cap biopharmaceutical company focused primarily on treating rare diseases, were down by as much as 10% as of 11:00 a.m. EST Wednesday after news broke that there is ...

Retrophin, Inc. Competitors & Peer Analysis - Health Technology Sector

Comparative analysis of Retrophin, Inc. against industry peers and competitors in the Health Technology sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Retrophin, Inc. Stock Forecast

How accurate are Retrophin, Inc. stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for RTRX predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Retrophin, Inc. stock price forecasts?

Our analysis considers Retrophin, Inc.'s financial metrics, Health Technology sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Retrophin, Inc. a good investment in 2025?

Based on our AI analysis, Retrophin, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Retrophin, Inc. forecasts updated?

Retrophin, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Retrophin, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Retrophin, Inc. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...